Mike Totzke

Riv Capital And Cansortium Shareholders Approve Merger: Combined Weed Company Will Operate In Four Major US States

RIV Capital's 111% Revenue Surge Amid NY Expansion, Prepares For Major Merger With Cansortium Cannabis Co.

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

RIV Capital's 111% Revenue Surge Amid NY Expansion, Prepares For Major Merger With Cansortium Cannabis Co.

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

This Cannabis Merger Will Cover 25% Of U.S. Population: Cansortium & RIV Capital Powered By ScottsMiracle-Gro

RIV Capital's Subsidiary, Etain Secures Regulatory Nod To Enter New York's Cannabis Market

This Cannabis Merger Will Cover 25% Of U.S. Population: Cansortium & RIV Capital Powered By ScottsMiracle-Gro

RIV Capital's Subsidiary, Etain Secures Regulatory Nod To Enter New York's Cannabis Market

Etain Receives Regulatory Approval For Cannabis Facility In Buffalo, New York

RIV Capital Q4 FY23 Revenue Declines 10.5% Hit By Illicit Market And Statewide Decline In Medical Cannabis Sales

Mike Totzke Recent News

Riv Capital Stock Trading Higher On Stagnating Q3 FY23 Revenue And CEO Departing

RIV Capital Inc. (OTCPK:CNPOF) (CSE:RIV) released its financial results for the three months ended December 31, 2022, revealing net revenue of $1.9 million, consistent with the previous quarter (the company did not report revenue for any reporting periods ended on or prior to March 31, 2022).

Riv Capital Cuts FY 22 Net Loss By 61%, Expects Completion Of Etain Acquisition In H2 22

RIV Capital Inc.’s (OTCPK:CNPOF) (CSE:RIV) total comprehensive loss in 2022 was CA$52.23 million ($40.61 million) compared to income of CA$67.32 million in fiscal 2021.